GAM Systematic’s Pfizer PFE Stock Holding History

GAM Systematic’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.28M	Buy	37,761 +18,637	+97%	+$599K	0.18%	215
2017 Q2	$609K	Buy	19,124 +8,462	+79%	+$267K	0.09%	378
2017 Q1	$346K	Buy	10,662 +8,659	+432%	+$273K	0.07%	427
2016 Q4	$62K	Sell	2,003 -54,036	-96%	-$1.65M	0.01%	553
2016 Q3	$1.8M	Buy	56,039 +21,995	+65%	+$735K	0.38%	43
2016 Q2	$1.14M	Sell	34,044 -25,320	-43%	-$808K	0.27%	115
2016 Q1	$1.67M	Sell	59,364 -4,284	-7%	-$122K	0.44%	21
2015 Q4	$1.95M	Sell	63,648 -7,352	-10%	-$231K	0.56%	9
2015 Q3	$2.12M	Sell	71,000 -175,299	-71%	-$5.62M	0.49%	9
2015 Q2	$7.83M	Buy	246,299 +31,055	+14%	+$1.01M	0.99%	3
2015 Q1	$7.11M	Buy	215,244 +95,696	+80%	+$3.04M	0.98%	3
2014 Q4	$3.53M	Buy	+119,548	New	+$3.43M	0.72%	12

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GAM Systematic's PFE Position: Q3 2017 in Review

GAM Systematic increased its Pfizer (PFE) stake by 97% in Q3 2017, buying an estimated $599K and bringing the position to 37,761 shares worth $1.28M. The position accounts for 0.18% of the portfolio, ranked #215.

GAM Systematic first reported a position in PFE in Q4 2014 and has held it in 12 quarters since. The position peaked at $7.83M in Q2 2015. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

GAM Systematic held 37,761 shares of Pfizer worth $1.28M as of Q3 2017.
GAM Systematic bought 18,637 Pfizer shares in Q3 2017, an estimated $599K.
Pfizer made up 0.18% of GAM Systematic's portfolio in Q3 2017, its #215 holding.
GAM Systematic first reported a position in Pfizer in Q4 2014 and has held it in 12 quarters since.
GAM Systematic's Pfizer position peaked at $7.83M in Q2 2015.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.